Mobile Health Innovator to Demo Proprietary Technology Engine and Share Vision for Future Growth
NEW YORK / Jun 14, 2023 / Business Wire / DocGo Inc (Nasdaq: DCGO), a leading provider of last-mile mobile health services, will be hosting an in-person Investor Day on Tuesday, June 20th, 2023 from 12:30–3:00 pm ET at the Nasdaq MarketSite in New York.
DocGo’s model is changing the future of healthcare delivery by bringing proactive mobile care to more people while lowering costs and improving outcomes. The event will include presentations from DocGo’s executive leadership team, and will feature the following:
Speakers will include:
A light lunch will be served at 12:30pm and presentations will start at 1:00 pm. A live question and answer session will follow the formal presentations. Only those attending in-person will be able to ask questions. To register for the event, please click here. Space is limited.
Venue: Nasdaq MarketSite, 151 W 43rd St., New York, NY 10036
A live webcast of the presentation and question and answer session will be accessible on June 20th starting at 1:00 pm ET on the Company's investor relations website. Click here for the website. Presentation slides will be posted on the day of the event, at approximately 1:00 pm ET, to the Company’s website at the same location above.
About DocGo
DocGo is a leading provider of last-mile mobile care services. DocGo is disrupting the traditional four-wall healthcare system by providing high quality, highly affordable care to patients where and when they need it. DocGo's innovative technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks, and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace. Together with Ambulnz by DocGo's integrated medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com.
Last Trade: | US$3.51 |
Daily Change: | 0.05 1.45 |
Daily Volume: | 524,355 |
Market Cap: | US$359.140M |
October 09, 2024 September 19, 2024 August 07, 2024 August 05, 2024 August 02, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORECue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB